AMCP 2022: Michael Ciarametaro of National Pharmaceutical Council Talks Gene Therapy, Medicaid Best Price Rule

Video
Conferences|AMCP Annual

Michael Ciarametaro, MBA, National Pharmaceutical Council National discusses gene therapy and the Medicaid Best Price Rule with MHE during the annual AMCP conference in Chicago.

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
Specialty Drugs Dominate Pharmaceutical Frontier in 2025

Specialty Drugs Dominate Pharmaceutical Frontier in 2025

Logan Lutton;Briana Contreras
September 14th 2025
Article

Read More

340B Program Is Driving Up Costs and Needs Urgent Reform | AMCP Annual 2025

340B Program Is Driving Up Costs and Needs Urgent Reform | AMCP Annual 2025

Pearl Steinzor;Briana Contreras
September 14th 2025
Article

Read More

MHE Week in Review – AMCP Annual 2025 Review

MHE Week in Review – AMCP Annual 2025 Review

Logan Lutton
September 14th 2025
Article

Read More

Costs of Hemophilia With Inhibitors Are High, Warranting Better Management | AMCP Annual 2025

Costs of Hemophilia With Inhibitors Are High, Warranting Better Management | AMCP Annual 2025

September 14th 2025
Article

Read More

Exploring the Wide World of GLP-1s | AMCP Annual 2025

Exploring the Wide World of GLP-1s | AMCP Annual 2025

Logan Lutton
September 14th 2025
Article

Read More

Amid Challenges, an Opportunity for PBMs To Do Business Differently, Says PCMA Leader | AMCP Annual 2025

Amid Challenges, an Opportunity for PBMs To Do Business Differently, Says PCMA Leader | AMCP Annual 2025

Logan Lutton
September 14th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.